Kuriakose Emil, Chief Medical Officer of Terns Pharmaceuticals ($TERN), sold shares on the open market five times in the last year, totaling about $58,000. His most recent sale occurred on January 2, 2026. These sales rank 10,231st among 11,678 insiders in our database, where the average is 8.6 million per person across 6.4 transactions. Emil made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 942 | $52.75 | 105,673.0000 | 91,701,529 | 0.88% | 0.00% |
| Jan. 14, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | A | Stock Option (Right to Buy) | 112500 | $0.00 | 112,500.0000 | 91,701,529 | 9999.99% | 0.12% |
| Jan. 14, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | A | Common Stock | 56250 | $0.00 | 106,615.0000 | 91,701,529 | 111.68% | 0.06% |
| Jan. 2, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 200 | $39.60 | 51,320.0000 | 91,701,529 | 0.39% | 0.00% |
| Jan. 2, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 955 | $38.36 | 50,365.0000 | 91,701,529 | 1.86% | 0.00% |
| Oct. 1, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 944 | $7.85 | 51,520.0000 | 91,701,529 | 1.80% | 0.00% |
| July 1, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 853 | $4.27 | 52,464.0000 | 79,507,474 | 1.60% | 0.00% |
| April 1, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 952 | $2.49 | 53,317.0000 | 79,507,474 | 1.75% | 0.00% |
| Jan. 30, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | A | Stock Option (Right to Buy) | 485000 | $0.00 | 485,000.0000 | 79,507,474 | 9999.99% | 0.61% |
| Jan. 2, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 4481 | $5.71 | 54,269.0000 | 79,507,474 | 7.63% | 0.01% |
| Dec. 12, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Kuriakose Emil | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 77,819,658 | 9999.99% | 0.15% |